EKEmily L. Kinney

Emily L. Kinney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emily L. Kinney has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Drew J. Stark

    Department of Medicine/Division of Infectious Diseases, University of Pittsburgh, Pennsylvania, United States of America

    3 shared publications
  • Laura A. Mike

    Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA

    3 shared publications
  • Saroj Khadka

    Department of Medicine/Division of Infectious Diseases, University of Pittsburgh, Pennsylvania, United States of America

    3 shared publications
  • William Bain

    Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA

    2 shared publications
  • Christine M. Tin

    Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA

    1 shared publication
  • Gabriella M. Gates

    Department of Medicine/Division of Infectious Diseases, University of Pittsburgh, Pennsylvania, United States of America

    1 shared publication

Latest Publications

  • Open Access

    Lipopolysaccharide and Wzi retain capsular polysaccharide at the Klebsiella pneumoniae cell surface and promote bloodstream infection fitness

    by Saroj Khadka, Zachary J. Resko, Grace E. Shepard, Emily L. Kinney, Gabriella M. Gates, Drew J. Stark, Laura A. Mike

    Bacterial capsules are formed by individual capsular polysaccharide (CPS) polymers and are the outermost extracellular layers of many Gram-positive and Gram-negative bacteria. Capsules affect several aspects of bacterial biology, including resistance to host immune factors, survival in unfavorable environments and antimicrobial resistance. Research on CPS biology has largely focused on its synthesis and the pathogenic consequences of its presence or absence. Beyond synthesis, our understanding of its retention (attachment) on the cell surface is limited. Klebsiella pneumoniae is an important Gram-negative pathogen and expresses more than 80 capsular serotypes using the common Wzy-dependent CPS biosynthesis system and phenotypically manifests in various forms, making this species an attractive bacterial model to study the underexplored aspects of CPS biology. Here, we identified and characterized bacterial components involved in CPS retention in K. pneumoniae and assessed the importance of CPS retention on bloodstream fitness. Our examination revealed that lipopolysaccharide (LPS) and the outer-membrane protein, Wzi, retain K. pneumoniae CPS on the bacterial surface. We demonstrate that the core-oligosaccharide domain of LPS and the extracellular surface of Wzi likely provide anchoring sites for CPS on the bacterial surface. Furthermore, CPS retention depends on divalent cation availability. Importantly, CPS retention on the bacterial surface is important for survival in serum and bacterial fitness at secondary infection sites in a murine bacteremia model. Our findings altogether demonstrate that the functional importance of CPS to bacteria extends beyond synthesis and its overall abundance. Bacterial control over other CPS properties, like cell surface retention, are also important for K. pneumoniae fitness during bacteremia.

  • Open Access

    Connections between Klebsiella pneumoniae bloodstream dynamics and serotype-independent capsule properties

    by Emily L. Kinney, Drew J. Stark, Saroj Khadka, Christine M. Tin, Timothy W. Hand, William Bain, Laura A. Mike

    Klebsiella pneumoniae bacteremia is a significant public health burden with a 26% mortality rate, which increases when the infecting isolate is multidrug resistant. An important virulence factor of K. pneumoniae is its capsule, the protective polysaccharide coat that surrounds the outer membrane and is made up of individual capsular polysaccharide (CPS) chains. The capsule can differ in composition, abundance, surface attachment, and length of the individual CPS chains. Long, uniform CPS chains are associated with a high level of mucoidy. Typically, mucoidy is produced by the hypervirulent K. pneumoniae (hvKp) pathotype, which is associated with invasive community-acquired infections. In contrast, the classical K. pneumoniae (cKp) pathotype tends to be less mucoid or non-mucoid and is associated with nosocomial infections and multidrug resistance. There are over 80 serotypes of K. pneumoniae capsule. Capsule swap experiments have begun to reveal the effect of serotype on virulence and immune interactions. Clinically, the K2 capsule serotype is a common serotype associated with neonatal bloodstream infections. Both cKp and hvKp can produce K2 capsule, but how K2-encoding cKp and hvKp strains differ in a bloodstream infection remains unknown. To fill this gap in knowledge, we characterized the surface properties of K2 serotype cKp and hvKp bloodstream infection isolates then tested the fitness of these strains in bloodstream infection-related in vitro and in vivo assays. Understanding how K2 cKp and hvKp strains differ in pathogenic potential provides further insights into how K. pneumoniae capsule properties influence bloodstream infection pathogenesis.


  • Open Access

    Connections between Klebsiella pneumoniae Bloodstream Dynamics and Serotype-Independent Capsule Properties

    by Emily L. Kinney, Drew J. Stark, Saroj Khadka, William Bain, Laura A. Mike

    Klebsiella pneumoniae bacteremia is a significant public health burden with a 26% mortality rate, which increases when the infecting isolate is multi-drug resistant. An important virulence factor of K. pneumoniae is the capsule, the protective polysaccharide coat which surrounds the outer membrane and is made up of individual capsular polysaccharide (CPS) chains. Capsule can differ in abundance, attachment, and length of the individual CPS chains. Long, uniform CPS chains are associated with a high level of mucoidy. Typically, mucoid CPS is produced by the hypervirulent K. pneumoniae (hvKp) pathotype, which is associated with invasive community-acquired infections. In contrast, the classical K. pneumoniae (cKp) pathotype tends to be non-mucoid and is associated with nosocomial infections and multi-drug resistance. There are over 80 serotypes of K. pneumoniae capsule. Capsule swap experiments have begun to reveal the effect of serotype on virulence and immune interactions. Clinically, the K2 capsule serotype is a common serotype associated with neonatal sepsis cases. Both cKp and hvKp can produce K2 capsule, but how K2-encoding cKp and hvKp strains differ in a bloodstream infection remains unknown. To fill this gap in knowledge, we characterized the surface properties of K2 serotype cKp and hvKp bloodstream infection isolates, then tested the fitness of these strains in bloodstream infection-related in vitro and in vivo assays. Understanding how K2 cKp and hvKp strains differ in pathogenic potential provides further insight into how K. pneumoniae capsule properties influence bloodstream infection pathogenesis. IMPORTANCE: Many studies have compared the pathogenesis of the two Klebsiella pneumoniae pathotypes, but did not control for differences in capsule serotype. In this study, we control for the K2 capsule serotype in classical and hypervirulent pathotypes. Our studies reveal that despite the two pathotypes exhibiting similar human serum survival, they display different tissue tropism in a murine bloodstream infection model. Additionally, although these pathotypes produce similar amounts of capsule, the hypervirulent strains are significantly more mucoid. Our study has provided more evidence on how capsule characteristics impact K. pneumoniae bacteremia pathogenesis and the importance of capsule serotype.